Report Published: "Global Migraine Drugs Market 2016-2020"

A migraine is characterized by repeated attacks of a severe headache, nausea, vomiting, and extreme sensitivity to light and sound. Women are more prone to the disease compared to men owing to the fluctuating levels of hormones in their bodies. Therapeutic agents such as anti-inflammatory painkillers, antimigraine drugs, antisickness medicines, and triptans are used for the treatment of the disease.

Technavio's analysts forecast the global migraine drugs market to grow at a CAGR of 4.56% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global migraine drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that will be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:

Full Report Details at
- http://www.fastmr.com/prod/1171561_global_migraine_drugs.aspx?afid=301

* Americas
* APAC
* EMEA

Technavio's report, Global Migraine Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

* Allergan
* Endo International
* GlaxoSmithKline
* Impax
* Pfizer

Other prominent vendors

* Abbott
* Aegis Therapeutics
* Aeriel BioPharma
* Alder Biopharmaceuticals
* Amgen
* Astellas
* AstraZeneca
* Bayer
* CoLucid
* Dr. Reddy's Laboratories
* Eisai
* Eli Lilly
* Ethypharm
* IntelGenx
* Johnson & Johnson
* Klaria
* Kowa Pharmaceuticals America
* Luitpold Pharmaceuticals
* Meda
* Merck
* OptiNose
* Pfizer
* Pozen
* Raptor
* RedHill
* SUDA
* Teva
* TG Therapeutics
* NValeant
* Winston Pharmaceuticals
* Zogenix

Market driver

* Growing awareness about migraine and its treatment options
* For a full, detailed list, view our report

Market challenge

* Lack of proper diagnosis
* For a full, detailed list, view our report

Market trend

* Antimigraine devices and headbands
* For a full, detailed list, view our report

Key questions answered in this report

* What will the market size be in 2020 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?
* What are the market opportunities and threats faced by the key vendors?

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Global Autoimmune Drugs Market 2016-2020
- Global Resipiratory Drugs Market 2016-2020
- Global Immunotherapy Drugs 2016-2020
- Global Acne Drugs Market 2016-2020
- Immunotherapy Drugs Market - Global Forecast to 2020